HealthTech for Lifescience Leaders

HealthTech for Lifescience Leaders

Home
Podcast
Notes
Archive
About
Is your new AI partner a liability?
Over 80% of AI projects fail. Here's how to pick the winners and avoid the costly mistakes everyone else is making in R&D.
16 hrs ago • 
Stephen Ranjan
October 24 - HealthTech Dose
Buying Blindfolded: The Vetting Strategy That Stops Healthcare AI Disasters
Oct 24 • 
Stephen Ranjan
12:36
Is your AI showing its work?
If not, you're making a high-stakes bet. Here's how to demand transparency and make smarter R&D decisions.
Oct 21 • 
Stephen Ranjan
1
1
October 17 - HealthTech Dose
The 3 Imperatives: AI-Driven Speed, Quality, and Differentiation in Drug Discovery & Development
Oct 17 • 
Stephen Ranjan
12:05
AI Ethics: Your R&D Blind Spot?
Don't let AI's dark side derail your next big breakthrough.Sub-title
Oct 14 • 
Stephen Ranjan
October 10 - HealthTech Dose
Progress vs. Precaution: Weighing the Risks of High-Autonomy AI in Pharma R&D
Oct 10 • 
Stephen Ranjan
11:30
AI Talent: Build or Partner? The R&D Dilemma.
Unlocking AI's potential in pharma R&D requires a strategic approach to expertise.
Oct 7 • 
Stephen Ranjan
October 3 - HealthTech Dose
Pharma AI's Triple Threat: Mastering Interactive Governance, Synchronization, and Strategy
Oct 3 • 
Stephen Ranjan
12:01
HealthTech for Lifescience Leaders
HealthTech for Lifescience Leaders
Writing about leadership, digital health, AI & product management within pharma and medical devices.
Recommendations
Trials & Triumphs
Trials & Triumphs
Zina Sarif
Clinical Trials - POS
Clinical Trials - POS
ClinicalTrialPOS
Healthtech Off The Record
Healthtech Off The Record
Dr. Lucas Mittelmeier
The CRA Wizard
The CRA Wizard
Tihomira Leteyski
User's avatar
HealthTech Beat
HealthTech Beat

HealthTech for Lifescience Leaders

AboutArchiveRecommendationsSitemap
© 2025 Stephen Ranjan
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture